Contrast media injectors market seen reaching $2.6 billion by 2030

Allied Market Research projects the global contrast media injectors market will grow from $1.40 billion in 2020 to $2.60 billion by 2030, driven by more cancer and cardiovascular cases and rising demand for MRI scans. Hospitals and consumables remain the biggest segments, while Asia-Pacific is expected to grow fastest.

Why it matters: - The contrast media injectors market is tied to diagnostic imaging used in cancer and cardiovascular care. - Growth in MRI and CT demand could support higher spending on injector systems, consumables and accessories. - The market is still sensitive to cost pressure, which could limit adoption in some settings.

What happened: - Allied Market Research estimated the global contrast media injectors market at $1.40 billion in 2020. - Allied Market Research expects the market to reach $2.60 billion by 2030. - The forecast implies a compound annual growth rate of 8.0% from 2021 to 2030. - The report covers product type, application, end user and region. - The report was published in Portland, Oregon.

The details: - Increasing cancer and cardiovascular disease prevalence is a major growth driver. - Unhealthy lifestyles are also fueling demand. - High costs for contrast media injectors, consumables and accessories are a restraint. - Rising demand for MRI scans is expected to create new opportunities. - The COVID-19 pandemic slowed elective surgeries and medical exams. - That slowdown reduced demand for contrast media injectors used to control contrast material during CT and MRI scans. - In product type, consumables accounted for more than two-thirds of the market in 2020. - The consumables segment is projected to remain the largest through 2030. - The consumables segment is expected to post the fastest CAGR at 8.5% during the forecast period. - In end users, hospitals represented more than half of market revenue in 2020. - Hospitals are expected to remain the top end-user segment through 2030. - Hospitals are also forecast to grow at an 8.5% CAGR. - North America held more than one-third of global market share in 2020. - North America is expected to keep the largest regional share through 2030. - Asia-Pacific is projected to post the fastest regional CAGR at 9.6% from 2021 to 2030. - The report also analyzes Europe and LAMEA. - Key companies in the market include Bracco Imaging S.P.A., Shenzhen Anke High-tech Co. Ltd., Guerbet Group, Ulrich GmbH & Co. KG, Nemoto Kyorindo Co., Ltd., Medtron AG, Sino Medical-Device Technology Co., Ltd., Bayer HealthCare LLC, APOLLO RT Co. Ltd. and Shenzen Seacrown Electromechanical Co Ltd. - These companies are using partnerships, expansion, collaboration and joint ventures to strengthen their positions. - The report includes a sample PDF at Download Your Exclusive Sample PDF Report. - The full report is available at Procure Complete Report.

Between the lines: - The report points to a recovery story after the pandemic, with imaging demand normalizing as health systems resume elective care. - Consumables and hospitals are likely to remain the main revenue pools because they are tied to recurring use and high imaging volumes. - Regional growth is shifting toward Asia-Pacific, even as North America remains the largest market.

What's next: - The market’s near-term trajectory will depend on imaging volumes, replacement cycles and health care spending. - Product makers are likely to keep competing through partnerships and geographic expansion. - Demand will likely track broader trends in chronic disease diagnosis and MRI adoption. - Allied Market Research also lists related reports on Real World Evidence Solutions, Animal Ultrasound, CAR T-Cell therapy and Pediatric Radiology.

The bottom line: - Contrast media injectors are set for steady growth through 2030, led by chronic disease imaging needs and recurring consumables demand.